Who is Hikma? It’s simple. We create high-quality medicines and make them accessible to the people who need them. That’s what we do.
Its what every one of our 9,400+ employees helps us to do. It’s what we’ve always done… ever since we began almost 50 years ago. Today, our headquarters are in London, but you will also find us in North America, Europe and the MENA region. With 3 main R&D locations, 29 manufacturing plants, with an established commercial infrastructure in our markets, we are global experts with a local presence. Across our sites we’re developing, manufacturing, and making available high-quality medicines for healthcare professionals and patients. 825+ products worldwide (as of Feb 2026) billions of doses annually.
Living our culture of progress and belonging.
Delivering our strategy.
Acting responsibly.
We turn cutting-edge science into innovative everyday solutions that transform people’s lives and make the world healthier.
Committed to quality.
Committed to people.
Committed to better health.
Better health. Within reach. Every day. We are Hikma
We are a leading global pharmaceutical company supplying more than 825 generic, specialty and branded products across North America, Europe and the Middle East and North Africa
Founded in 1978, Hikma is now a global pharmaceutical company serving patients across North America, the MENA region and Europe, and a leader in generics and specialty medicines grounded in quality and reliability.
We are one Hikma living a culture of progress and belonging, shaped by three values.
We support our people to grow and hold ourselves to high ethical and quality standards in every market we serve.
Leadership that drives progress
As global health needs evolve, our purpose continues to guide our strategy and ambition almost 50 years later. We are strengthening our capabilities, expanding our portfolio, and investing in our future, so we can continue to make a meaningful difference.
Our purpose is a promise to deliver high-quality medicines, to act with as a responsible business, and to help build a healthier future for all.
As global health needs evolve, our purpose continues to guide our strategy and ambition almost 50 years later. We are strengthening our capabilities, expanding our portfolio, and investing in our future, so we can continue to make a meaningful difference.
Our purpose is a promise to deliver high-quality medicines, to act with as a responsible business, and to help build a healthier future for all.
Hikma at a glance
825+ products
Across Injectables, Branded and Hikma Rx
29 manufacturing plants
Across North America, EU and MENA
3 R&D hubs
US, Jordan and Croatia
13 US FDA‑inspected facilities
12 EMA‑inspected facilities
9,400 empowered employees
Responsibility in action
We act responsibly by advancing health and wellbeing, empowering our people, protecting the environment, and building trust through quality in everything we do. We work in line with the standards of regulators across our markets, and we partner with healthcare providers, patient groups and communities to widen access to medicines.
Latest news
Hikma delivers Group revenue and profit growth and announces share buyback and leadership changes
- Hikma launches Sugammadex Injection in a prefilled syringe in the US Press Release, Product 29 July 2026 Hikma launches Sugammadex Injection in a prefilled syringe in the US
- Inspired at Hikma: Purpose-driven leadership, developing talent and building for growth. Meet Kristy Ronco Story, Life at Hikma 22 July 2026 Inspired at Hikma: Purpose-driven leadership, developing talent and building for growth. Meet Kristy Ronco
- Hikma launches Diazepam Injection, USP in the US Press Release, Product 08 July 2026 Hikma launches Diazepam Injection, USP in the US
- Hikma launches XCOPRI® (Cenobamate tablets) in the UAE Press Release, Product 06 July 2026 Hikma launches XCOPRI® (Cenobamate tablets) in the UAE